tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RXRX Stock Latest News

Recursion Pharmaceuticals Registers Shares for Resale
Company AnnouncementsRecursion Pharmaceuticals Registers Shares for Resale
1d ago
8K
RXRX
Hold Rating for Recursion Pharmaceuticals Amid Program Discontinuations and Financial Concerns
PremiumRatings
Hold Rating for Recursion Pharmaceuticals Amid Program Discontinuations and Financial Concerns
4d ago
RXRX
Recursion Pharmaceuticals price target lowered to $8 from $10 at BofA
PremiumThe Fly
Recursion Pharmaceuticals price target lowered to $8 from $10 at BofA
4d ago
RXRX
Cautious Outlook on Recursion Pharmaceuticals Amid Strategic Shifts and Early-Stage Developments
PremiumRatings
Cautious Outlook on Recursion Pharmaceuticals Amid Strategic Shifts and Early-Stage Developments
5d ago
RXRX
Recursion Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany Announcements
Recursion Pharmaceuticals Reports Q1 2025 Financial Results
5d ago
RXRX
Recursion Pharmaceuticals’ Earnings Call: Balancing Success and Challenges
PremiumCompany AnnouncementsRecursion Pharmaceuticals’ Earnings Call: Balancing Success and Challenges
5d ago
RXRX
Options Volatility and Implied Earnings Moves Today, May 05, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 05, 2025
5d ago
F
O
Recursion Pharmaceuticals Reports Q1 Results and Strategy Update
Premium
Company Announcements
Recursion Pharmaceuticals Reports Q1 Results and Strategy Update
5d ago
8K
RXRX
Recursion Pharmaceuticals reports Q1 EPS (50c), consensus (52c)
PremiumThe Fly
Recursion Pharmaceuticals reports Q1 EPS (50c), consensus (52c)
6d ago
RXRX
Recursion announces preliminary results from Phase 1b/2 TUPELO trial
PremiumThe Fly
Recursion announces preliminary results from Phase 1b/2 TUPELO trial
6d ago
RXRX
Is RXRX a Buy, Before Earnings?
PremiumPre-Earnings
Is RXRX a Buy, Before Earnings?
8d ago
RXRX
Recursion to present clinical data from ongoing Phase 1b/2 trial of REC-4881
PremiumThe Fly
Recursion to present clinical data from ongoing Phase 1b/2 trial of REC-4881
18d ago
RXRX
BTIG Analyst Sees Tempus AI (TEM) as “Significant Free Call Option” with 48% Upside
PremiumMarket NewsBTIG Analyst Sees Tempus AI (TEM) as “Significant Free Call Option” with 48% Upside
19d ago
TEM
ILMN
Recursion and HealthVerity announce agreement
Premium
The Fly
Recursion and HealthVerity announce agreement
24d ago
RXRX
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
25d ago
BHP
EXK
Cathie Wood’s ARK Investment buys 460K shares of Recursion Pharmaceuticals today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 460K shares of Recursion Pharmaceuticals today
26d ago
RXRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
26d ago
CDT
PTN
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
29d ago
RXRX
Recursion Pharmaceuticals price target lowered to $8 from $10 at Morgan Stanley
PremiumThe Fly
Recursion Pharmaceuticals price target lowered to $8 from $10 at Morgan Stanley
1M ago
RXRX
Recursion Pharmaceuticals, Enamine release new tools in its AI/ML platform
PremiumThe FlyRecursion Pharmaceuticals, Enamine release new tools in its AI/ML platform
1M ago
RXRX
Recursion announces first patient dosed in Phase 1 REC-3565 study
Premium
The Fly
Recursion announces first patient dosed in Phase 1 REC-3565 study
1M ago
RXRX
Strategic Positioning and Operational Resilience Justify Buy Rating for Recursion Pharmaceuticals
Premium
Ratings
Strategic Positioning and Operational Resilience Justify Buy Rating for Recursion Pharmaceuticals
1M ago
RXRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >